|

Patient-Specific 3D Action Observation Training in Parkinson's Disease

RECRUITINGN/ASponsored by Abant Izzet Baysal University
Actively Recruiting
PhaseN/A
SponsorAbant Izzet Baysal University
Started2025-12-15
Est. completion2027-07-15
Eligibility
Age50 Years – 85 Years
Healthy vol.Accepted

Summary

Although studies exist demonstrating the effects of single-session action observation training on bradykinesia in patients with Parkinson's disease, research investigating the long-term application of such training remains limited. Furthermore, the broader literature indicates that action observation training has typically been conducted in simulated environments or by using recordings obtained from healthy individuals. The aim of the present study is to examine the effects of action observation training, delivered in a fully immersive virtual reality environment using each patient's own 3D motion recordings, on bradykinesia and other disease-related parameters.

Eligibility

Age: 50 Years – 85 YearsHealthy volunteers accepted
Inclusion Criteria:

* Voluntary agreement to participate in the study
* Clinical diagnosis of Parkinson's disease confirmed by a neurologist
* Ongoing treatment with antiparkinsonian medication
* Hoehn and Yahr (H-Y) stage ≤ 3
* Ability to walk independently

Exclusion Criteria:

* Presence of additional neurological disorders other than Parkinson's disease
* Change in medication dosage within the past month
* Score of ≥ 10 on the Simulator Sickness Questionnaire
* Presence of amblyopia, strabismus, or pathologies impairing focus, depth perception, or normal 3D vision
* Failure on the butterfly test of the Titmus stereotest (greater than 3,552 seconds of arc)

Conditions6

3d RecordingAction Obervation TrainingImmersive Virtual RealityParkinson DiseaseParkinson's DiseaseVirtual Reality

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.